These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 781133)

  • 21. Latent lymphokines: isolation of guinea pig latent lymphocyte-derived chemotactic factor for monocytes. Its activation by trypsin and a soluble factor from macrophages.
    Postlethwaite AE; Kang AH
    J Immunol; 1979 Aug; 123(2):561-7. PubMed ID: 458146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
    Farram E; Geczy CL; Moon DK; Hopper K
    J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive production of lymphokines by cloned murine B-cell lymphomas--CH12 B lymphoma produces interleukin-4.
    O'Garra A; Barbis D; Harada N; Lee F; Howard M
    J Mol Cell Immunol; 1989; 4(3):149-58; discussion 158-9. PubMed ID: 2788429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
    Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
    J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphokine production in primary mixed lymphocyte culture (MLC). III. Alloantigen signals cell-cell interactions involved in migration inhibition factor and immune interferon release.
    Landolfo S; Giovarelli M; Capusso A; Forni G
    Boll Ist Sieroter Milan; 1979 May; 58(2):128-32. PubMed ID: 95480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes.
    Rocklin RE; Chess L; MacDermott RP; Schlossman SF; David JR
    Rheumatology; 1975; 6():98-105. PubMed ID: 1105751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of a human T lymphocyte chemotactic factor by T cell subpopulations.
    Van Epps DE; Potter JW; Durant DA
    J Immunol; 1983 Jun; 130(6):2727-31. PubMed ID: 6222116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteria induce lymphokine synthesis polyclonally in human B lymphocytes.
    Räsänen L; Karhumäki E; Arvilommi H
    J Immunol; 1978 Aug; 121(2):418-20. PubMed ID: 98583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of T-cells synthesizing macrophage migration inhibition factor in an H-2 system].
    Suslov AP; Brondz BD; Egorova SG
    Biull Eksp Biol Med; 1978 Jun; 85(6):701-4. PubMed ID: 352434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.
    Zachariae CO
    Acta Derm Venereol Suppl (Stockh); 1993; 181():1-37. PubMed ID: 7901957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory, non-antibody lymphocytic mediators (lymphokines).
    Bendtzen K; Bendixen G
    Allerg Immunol (Leipz); 1980; 26(4):293-309. PubMed ID: 6163346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to guinea pig lymphokines. VII. Reactivity with products of lymphoid and nonlymphoid cells.
    Sorg C; Geczy CL
    J Immunol; 1978 Sep; 121(3):1199-205. PubMed ID: 99476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    Biondi A; Roach JA; Schlossman SF; Todd RF
    J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of lymphokines produced by human T-T hybridomas on the proliferation of normal and neoplastic B lymphocytes].
    Gambatesa V
    Medicina (Firenze); 1989; 9(2):184-7. PubMed ID: 2811645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Action mechanism of lymphocytic mediators in cell-mediated immunologic reactions].
    Yoshida T
    Union Med Can; 1979 Jun; 108(6):698-704. PubMed ID: 388783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.